Literature DB >> 15333497

Lipids and glucose in type 2 diabetes: what is the cause and effect?

Guenther Boden1, Markku Laakso.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15333497     DOI: 10.2337/diacare.27.9.2253

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  37 in total

1.  Postprandial lipaemia induces an acute decrease of insulin sensitivity in healthy men independently of plasma NEFA levels.

Authors:  M T Pedrini; A Niederwanger; M Kranebitter; C Tautermann; C Ciardi; T Tatarczyk; J R Patsch
Journal:  Diabetologia       Date:  2006-04-26       Impact factor: 10.122

2.  Pioglitazone and nonalcoholic steatohepatitis.

Authors:  Guenther Boden
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

3.  Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice.

Authors:  Lu Gan; Dina Xie; Jing Liu; Wayne Bond Lau; Theodore A Christopher; Bernard Lopez; Ling Zhang; Erhe Gao; Walter Koch; Xin-Liang Ma; Yajing Wang
Journal:  Circulation       Date:  2020-01-10       Impact factor: 29.690

4.  Hip circumference and the risk of type 2 diabetes in middle-aged and elderly men and women: the Shanghai women and Shanghai men's health studies.

Authors:  Baqiyyah Conway; Yong-Bing Xiang; Raquel Villegas; Xianglan Zhang; Honglan Li; Xiaoyan Wu; Gong Yang; Yu-Tang Gao; Wei Zhang; Xiao-Ou Shu
Journal:  Ann Epidemiol       Date:  2011-05       Impact factor: 3.797

Review 5.  Management of dyslipidemia in people with type 2 diabetes mellitus.

Authors:  Fredrick L Dunn
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

Review 6.  Effect of ezetimibe on glycemic control: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Huijin Wu; Hua Shang; Jing Wu
Journal:  Endocrine       Date:  2018-02-03       Impact factor: 3.633

7.  Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study.

Authors:  Carlos Lorenzo; Sara Hartnett; Anthony J Hanley; Marian J Rewers; Lynne E Wagenknecht; Andrew J Karter; Steven M Haffner
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

8.  The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population.

Authors:  Yun Qian; Yudi Lin; Tiemei Zhang; Jianling Bai; Feng Chen; Yi Zhang; Senlin Luo; Hongbing Shen
Journal:  BMC Public Health       Date:  2010-03-17       Impact factor: 3.295

9.  Evaluation of quantitative models of the effect of insulin on lipolysis and glucose disposal.

Authors:  Vipul Periwal; Carson C Chow; Richard N Bergman; Madia Ricks; Gloria L Vega; Anne E Sumner
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-08-06       Impact factor: 3.619

Review 10.  Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.

Authors:  Harold Bays; Carlos A Dujovne
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.